Humacyte
Global leader in engineering regenerative medicine products to save and improve patient lives. Learn more
Launch date
Employees
Market cap
$673m
Enterprise valuation
$598m (Public information from Sep 2024)
Share price
$5.45 HUMA
Durham North Carolina (HQ)
Authorizing premium user...